-glutamylcysteine synthetase (-GCS) is the first rate-limiting enzyme of glutathione synthesis
Ozempic, however, is narrowly indicated for the treatment of type 2 diabetes, focusing its efficacy on improving blood sugar levels in adults, and is not approved for weight management despite potential weight-reducing side effects that may benefit some patients
Many people reach for stimulants or common supplements for a mental lift, but peptides offer a smarter, more sustainable approach
Cons: Effects are subtle and cumulativeno immediate visible change
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD et al (2021) Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes